IntoCell, Inc. (KOSDAQ:287840)
South Korea · Delayed Price · Currency is KRW 14,890
+1,390 (10.30%)
At close: Oct 16, 2026
IntoCell Market Cap
IntoCell has a market cap or net worth of 223.68 billion as of October 16, 2026. It is the 22,502nd most valuable company in the world and the 829th biggest in South Korea. Its market cap has decreased by 62.34% in one year.
Market Cap
223.68B
Enterprise Value
209.98B
Revenue
3.19B
Global Rank
Country Rank
#829 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since May 23, 2025, IntoCell's market cap has decreased from 492.33B to 223.68B, a decrease of -54.57%. That is a compound annual growth rate of -43.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 223.68B | -74.02% |
| Dec 30, 2025 | 861.05B | 74.89% |
| May 23, 2025 | 492.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inventage Lab | 321.38B |
| S.Biomedics | 250.80B |
| HansBiomed | 248.01B |
| Genome & Company | 220.70B |
| IMBiologics | 210.68B |
| curacle co.,ltd. | 187.23B |
| Kangstem Biotech | 172.21B |
| NIBEC | 157.10B |